SCHEMBL30989832

SCHEMBL30989832

CCN(Cc1cccc(F)c1)C(=O)c1cc(Cl)cnc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSPO P30536 1/20 0.43
▸ PKM P14618 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ROCK2 O75116 2/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ MAPK1 P28482 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MITF O75030 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ RIPK1 Q13546 1/20 0.38
▸ CLK1 P49759 1/20 0.38
▸ CLK2 P49760 1/20 0.38
▸ DYRK1A Q13627 1/20 0.38
▸ CLK4 Q9HAZ1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30989909 0.87 CLK1 (0.48) MEN1KMT2AROCK2ROCK1MAPK1
SCHEMBL30989970 0.82 MAPT (0.44) TSPOMEN1KMT2AROCK2ROCK1
SCHEMBL30989948 0.78 TP53 (0.55) KMT2AROCK2ROCK1MAPK1RIPK1
SCHEMBL30989952 0.78 TP53 (0.55) KMT2AROCK2ROCK1MAPK1RIPK1
SCHEMBL30989864 0.77 CLK1 (0.51) MEN1KMT2AALDH1A1RIPK1CLK1
SCHEMBL30989923 0.76 ALDH1A1 (0.47) MEN1KMT2AALDH1A1HTTRIPK1
SCHEMBL30989886 0.76 CLK1 (0.44) RIPK1CLK1CLK2DYRK1ACLK4
SCHEMBL30989930 0.74 HSP90AA1 (0.52) MEN1KMT2AROCK2ROCK1ALDH1A1
SCHEMBL30989813 0.74 CLK1 (0.43) RIPK1CLK1CLK2DYRK1ACLK4
SCHEMBL30989898 0.73 GPBAR1 (0.42) MEN1KMT2AMAPK1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612131-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024095003-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2024-05-10 — — WO disclosed
Send feedback